Encompass Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Encompass Health generated cash of $850,800,000, which is more than the previous year. Cash used in financing activities reached the amount of -$197,200,000 last year. Net change in cash is therefore $50,800,000.
Cash Flow
| 2014 | 444.9M | -876.9M | 434.2M |
|---|---|---|---|
| 2015 | 484.8M | -1.12B | 639.9M |
| 2016 | 605.5M | -245M | -381.6M |
| 2017 | 657.2M | -284.5M | -359.9M |
| 2018 | 762.4M | -424.5M | -321.2M |
| 2019 | 635.3M | -657.4M | 48.2M |
| 2020 | 704.7M | -407.5M | -145.9M |
| 2021 | 715.8M | -666.3M | -240.1M |
| 2022 | 705.8M | -627M | -145.7M |
| 2023 | 850.8M | -602.8M | -197.2M |
EHC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 53.4M | 120.3M | 310.9M | 159.6M | 133.5M | 116.8M | 40.5M | 61.6M | 66.7M | 64.5M |
Operating activities | ||||||||||
Net income | 361.6M | 365.9M | 517.6M | 368.8M | 446.4M | 374.3M | 335.8M | 318.1M | 253.7M | 276.2M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 273.9M | 243.6M | 256.6M | 243M | 218.7M | 199.7M | 183.8M | 172.6M | 139.7M | 107.7M |
Stock-based compensation expense | 50.6M | 29.2M | 29.1M | 25.6M | 114.4M | 85.9M | 47.7M | 27.4M | 26.2M | 23.9M |
| Deferred income tax benefit | 50.6M | 29.2M | 29.1M | 25.6M | 114.4M | 85.9M | 47.7M | 27.4M | 26.2M | 23.9M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -22.4M | -16.9M | -64.3M | -38.1M | -22.9M | 7M | -83.9M | -127.5M | -134.1M | -91.6M |
Inventories | 0 | 0 | 0 | 0 | 0 | -2.4M | 25.9M | 18.3M | -13.9M | -3.9M |
Accounts payable | 11.8M | 2.3M | 14.9M | 13.6M | -6.1M | 6.6M | 7.5M | 6.3M | 900K | 5.4M |
Cash generated by operating activities | 850.8M | 705.8M | 715.8M | 704.7M | 635.3M | 762.4M | 657.2M | 605.5M | 484.8M | 444.9M |
Investing activities | ||||||||||
Purchases Of Investments | -23M | -35.2M | -9M | -8.7M | -32.9M | -13.3M | -8.5M | -1.3M | -7.1M | -3.5M |
Investments In Property Plant And Equipment | -583.1M | -584.1M | -551.2M | -408.2M | -404.1M | -270.5M | -245M | -202.9M | -156.5M | -187.9M |
Acquisitions Net | 0 | 64.09M | -118.6M | -1.1M | -231.5M | -143.9M | -38.8M | -48.1M | -985.1M | -694.8M |
Cash generated by investing activities | -602.8M | -627M | -666.3M | -407.5M | -657.4M | -424.5M | -284.5M | -245M | -1.12B | -876.9M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 7.3M | 6.1M | 1.32B | 0 | 403.8M | 0 | 335M | 0 | 1.07B |
Payments for dividends | -60.4M | -99M | -112.2M | -111.8M | -108.7M | -100.8M | -91.5M | -83.8M | -80.3M | -72.1M |
Repurchases of common stock | -8.19M | -7.3M | -6.1M | -6.1M | -45.9M | -65.59M | -38.1M | -65.6M | -45.3M | -43.1M |
Repayments of term debt | -83.3M | -498.2M | -331.3M | -1.11B | 476M | -428.5M | -202.2M | -528.4M | 814.7M | -468.7M |
Cash used in financing activities | -197.2M | -145.7M | -240.1M | -145.9M | 48.2M | -321.2M | -359.9M | -381.6M | 639.9M | 434.2M |
Net Change In Cash | 50.8M | -66.9M | -190.6M | 151.3M | 26.1M | 16.7M | 13.9M | -21.1M | -5.1M | 2.2M |
Cash at end of period | 104.2M | 53.4M | 120.3M | 310.9M | 159.6M | 133.5M | 54.4M | 40.5M | 61.6M | 66.7M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |